Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
18:31
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 20th Annual Conference
    Topic - Therapy & Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 107
Visits: 48
Title: Effect Of Pembrolizumab (Pembro) On Hepatitis B Virus (Hbv) Load And Aminotransferase (Alt) Levels In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) In Keynote-224 And Keynote-240
Authors: Philippe Merle , P. MERLE, S.L. CHAN, A.X. ZHU, R.S. FINN, J. EDELINE, S. OGASAWARA, J.J. KNOX, B. DANIELE, B.-Y. RYOO, M. BOUATTOUR, H.-Y. LIM, Y. CHAO, T. YAU, B.A. HABER, U. MALHOTRA, C.-C. LIU, M. KUDO, A.-L. CHENG
Centre: 

You must be registered to reply or comment.

EFFECT OF PEMBROLIZUMAB (PEMBRO) ON HEPATITIS B VIRUS (HBV) LOAD AND AMINOTRANSFERASE (ALT) LEVELS IN PATIENTS (PTS) WITH ADVANCED HEPATOCELLULAR CARCINOMA (AHCC) IN KEYNOTE-224 AND KEYNOTE-240

Neehar Parikh
Thread initiator
Subspeciality
Reg: 9/1/2020 7:36:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 9/22/2020 1:28:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre: 

Poster most viewed in this topic
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert